Dr. Michael Harder


Dr. Harder set up corlife in 2006 and became a shareholder and partner in 2011. Between 2000 and 2006 Dr Harder was managing director of Pharis Biotec. During his leadership, the company outlicensed technology, consolidated the R&D activities and organized a full funding with private equity. Dr Harder joined Merck KGaA in 1995 and spent 5 years in R&D as a project and team leader. Dr Harder holds a PhD in Biotechnoloy from the University of Braunschweig and conducted postdoctoral training in Tübingen.